Bayan Health review

Bayan’s current standard compounded GLP-1 pages list $129 monthly for semaglutide and $149 for tirzepatide, with medication, consultation and expedited shipping included. The pages describe the same price at different prescribed doses and no membership fee. That is a current product offer, not a guarantee that every future renewal or unrelated preparation will keep the same price. General terms reserve the possibility of renewal-price changes. Ask for the selected protocol’s complete charges, formulation and supply before payment. The tirzepatide cost guide shows how to compare an installment plan with an unrestricted monthly purchase.

The product pages require an initial 90-day commitment, billed monthly and described as noncancelable during that period. They say a three-month medication supply is sent together after approval. General terms likewise explain that monthly installments pay for the entire protocol already prescribed and dispensed, rather than a fresh shipment each month. Stopping use or deciding against another injection does not automatically eliminate the remaining payment obligation. Confirm the actual quantity, use-by date, storage requirements and what happens if a clinician changes or stops the prescription. A multi-month vial supply should not be treated as permission to keep an opened vial indefinitely; follow the assigned pharmacy’s preparation-specific directions.

Renewal instructions differ across the pages. The product summary describes month-to-month continuation after the initial period and cancellation before the next billing date. The current terms instead require opting out at least 15 days before the next protocol cycle, which can be another 60- or 90-day program. Ask whether the next charge starts a new committed protocol or is simply another installment on the existing one, and get the relevant date in writing. A monthly debit on a bank statement does not settle that distinction. Keep cancellation confirmation and an itemized record of the remaining supply and payments rather than assuming a request ends every obligation immediately.

Refund thresholds are more nuanced than a blanket statement that every fee is retained after any denial. The terms say consultation fees are generally nonrefundable once clinical review begins. Medication may become nonrefundable when prescribed, processed, compounded, dispensed, shipped or otherwise prepared; the relevant stage needs confirmation for the selected order. Shipment discrepancies or damage must normally be reported in writing within 24 hours of delivery, with specified exceptions for documented loss, carrier error or circumstances outside the patient’s reasonable control. Inspect the order promptly and follow pharmacy instructions if temperature or integrity is in question. Shipping timelines are estimates, and cancellation or refund rights should not be inferred from a delivery estimate.

Bayan’s FAQ names MDIntegrations as its clinical network and describes video, audio or secure-message care, with testing when needed. This is a provider disclosure rather than independent verification of the treating clinician’s credentials, authority in your state or final dispensing pharmacy. The FAQ’s broad national availability is qualified by state rules, clinical approval and pharmacy capacity. Laboratory panels are separate offerings, and clinical requirements can make testing necessary even when a panel is marketed as optional. Lower-dose GLP-1 and peptide listings do not prove a wellness benefit, reduced risk or equivalent effects to approved brands. Regulatory status must be assessed ingredient by ingredient; an investigational catalog item does not establish an ordinary lawful access pathway. The microdose evidence article, pharmacy guide and tirzepatide lineup provide follow-up questions without turning the catalog into a treatment recommendation.